Invest now in Preclinical Phase in novel drug molecule for the treatment of Melasma
ABOUT
Team
APPROACH
PIPELINE
ROADMAP
INVEST NOW
CONTACT
Contact
Europe office
Melasma Pharmaceuticals
38A, Karamfil Street, 1616, Sofia, Bulgaria
+359 888531345
investors@melasma.life
www.melasma.life